8[5]FDA.FDA Approves Thalomid (thalidomide) to Treat Multiple Myeloma[EB/OL].http://www.fda.gov/cder/Offices/OODP/what mew/thalidomide.hun,2006-07-20/2008-02-07.
9[6]EMEA.European Medicines Agency recommends the approval of thalidomide for the treatment of rate bone-marrow cancer[EB/OL].http://www.emea.enropa.eu/pdfs/human/press,2008-01-24/2008-02-07.
10[7]FDA.FDA approves lenalidomide oral capsules (Revlimid) for use in combination with dexamethasone in patients with multiple myeloma[EB/OL],http://www.fda.gov/cder/Offices/OODP/what snew/lenalidomide.htm,2006-7-20/2008-02-07.
6Lainer DT,Brahn E. New anti-angiogenic strategies for the treatment of proliferative synovitis[J]. Expert Opin In- vest Drugs, 2005,14(1): 1-17.
7Scott BB, Zaratin PF, Cilmartin AG, et al. TNF-alpha modulates angiopoietin-1 expression in rheumatoid syn- ovial fibroblasts via the NF-kappa B signalling pathway. Biochem Biophys Res Commun, 2005,328(3):409-414.
8Thompson M A, Witzig T E, Kumar S et al. Plasma levels of tumournecrosis factor alpha and interleuk in-6 predict progression-free survival following thalidomide the rapy in patients with previously untredted mulitip lemyeloma[J]. Haematol, 2003, 123(2):305-308.
9Liu H,Gaspari AA,Schleichert R.Use of lenalidomide in treating refractory prurigo nodularis[J].J Drugs Dermatol, 2013,12(3) : 360-361.
